SECO, IBD Partner to Create New Ventilators, Combat COVID-19

April 23, 2020

News

SECO, IBD Partner to Create New Ventilators, Combat COVID-19

Respira is a non-invasive pulmonary ventilator created to help combat the COVID-19 pandemic.

SECO announced a partnership with IBD, an Italian company developing products for the biomedical market, to develop Respira. Respira is a non-invasive pulmonary ventilator created to help combat the COVID-19 pandemic.

“It gives me great pride that in such difficult times two Italian industry leaders like SECO and IBD have brought together their technological competencies to provide a tangible contribution to the healthcare system and its patients, through an innovative, non-invasive and portable solution for pulmonary ventilation,” said CEO of SECO Massimo Mauri, in a press release.

The new ventilator is a compact and portable high-flux, pulmonary ventilator for patients with COVID-19-related pneumonia. Respira is operational in both domestic and hospital environments. They bypass the need for invasive intubation and are equipped with touchscreen displays for easy and intuitive use.

Other uses of Respira include immunodepressions cases and oxygenation in both pre- and post-intensive care.

Deliveries of the ventilators are expected between late May and early June, according to the companies.

For more information, visit https://www.seco.com/it/ or https://www.ibdbiomed.com/.

Featured Companies

SECO USA

Via A. Grandi 20
Arezzo, 52100

IBD

Perry Cohen, associate editor for Embedded Computing Design, is responsible for web content editing and creation in addition to podcast production. He also assists with the publication?s social media efforts which include strategic posting, follower engagement, and social media analysis. Before joining the ECD editorial team, Perry has been published on both local and national news platforms including KTAR.com (Phoenix), ArizonaSports.com (Phoenix), AZFamily.com, Cronkite News, and MLB/MiLB among others. Perry received a BA in Journalism from the Walter Cronkite School of Journalism and Mass Communications at Arizona State university. He can be reached by email at [email protected]. Follow Perry?s work and ECD content on his twitter account @pcohen21.

More from Perry